Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trialRury R. Holman, Naveed Sattar, Huimei Feng et al.|The Lancet Diabetes & Endocrinology|2017Cited by 325
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma <i>in situ</i> of the bladderMichael S. Cookson, Ronald Tutrone, Sam S. Chang et al.|Therapeutic Advances in Urology|2014Cited by 50